Dr Jilly Evans PhD FRSNZ (Hon) is the Chief Scientific Officer and Co-founder of US-based biopharmaceutical company PharmAkea Therapeutics.
With more than 30 years’ experience conducting biochemistry research, she is a world-leading authority in the eicosanoid field (molecules that control inflammation and immunity).
Jilly is a founding member of the Maurice Wilkins Centre Scientific Advisory Board and an honorary fellow of the Royal Society of New Zealand.
In 2016, she was named in the Top 50 Women of Achievement complied by Zonta Clubs New Zealand.
Jilly is a passionate advocate for women in science and contributes to causes to alleviate childhood poverty and help New Zealand better commercialise biotechnology research.